-
1
-
-
0001667150
-
The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care : The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
-
ALLHAT Officers and coordinators for the ALLHAT collaborative research group
-
ALLHAT Officers and coordinators for the ALLHAT collaborative research group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care : The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT). JAMA 2002;18:2998-307.
-
(2002)
JAMA
, vol.18
, pp. 2998-3307
-
-
-
2
-
-
0037420492
-
ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial - lipid lowering arm (ASCOT-LLA) : A multicentre randomised controlled trial
-
Sever PS, Dahlöf B, Poulter NR, et al. ; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial - lipid lowering arm (ASCOT-LLA) : A multicentre randomised controlled trial. Lancet 2003;361:1149-58.
-
(2003)
Lancet
, vol.361
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlöf, B.2
Poulter, N.R.3
-
3
-
-
9144248446
-
Hypertension treatment and control in five European countries, Canada, and the United States
-
Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7.
-
(2004)
Hypertension
, vol.43
, pp. 10-17
-
-
Wolf-Maier, K.1
Cooper, R.S.2
Kramer, H.3
-
4
-
-
42449133365
-
The CoLaus study : A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome
-
Firmann M, Mayor V, Vidal PM, et al. The CoLaus study : A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6.
-
(2008)
BMC Cardiovasc Disord
, vol.8
, pp. 6
-
-
Firmann, M.1
Mayor, V.2
Vidal, P.M.3
-
5
-
-
52949154058
-
-
Submitted
-
Danon-Hersch N, Marques-Vidal P, Bovet P, et al. Prevalence, awareness, treatment, and control of hypertension in a Swiss general population : The CoLaus study. Submitted.
-
Prevalence, awareness, treatment, and control of hypertension in a Swiss general population : The CoLaus study
-
-
Danon-Hersch, N.1
Marques-Vidal, P.2
Bovet, P.3
-
6
-
-
7444221935
-
Promouvoir l'adhésion au traitement du patient dans le cadre d'une collaboration pharmaciens et médecins.
-
Santschi V, Favrat B, Bugnon O, et al. Promouvoir l'adhésion au traitement du patient dans le cadre d'une collaboration pharmaciens et médecins. Med Hyg 2004;62:2069-73.
-
(2004)
Med Hyg
, vol.62
, pp. 2069-2073
-
-
Santschi, V.1
Favrat, B.2
Bugnon, O.3
-
7
-
-
38549098101
-
Medication compliance and persistence : Terminology and definitions
-
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence : Terminology and definitions. Value Health 2008;11:44-7.
-
(2008)
Value Health
, vol.11
, pp. 44-47
-
-
Cramer, J.A.1
Roy, A.2
Burrell, A.3
-
8
-
-
1642397582
-
Variations in patients' adherence to medical recommendations : A quantitative review of 50 years of research
-
DiMatteo MR. Variations in patients' adherence to medical recommendations : A quantitative review of 50 years of research. Med Care 2004;42:200-9.
-
(2004)
Med Care
, vol.42
, pp. 200-209
-
-
DiMatteo, M.R.1
-
9
-
-
33750301096
-
Medication adherence and persistence as the cornerstone of effective antihypertensive therapy
-
Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190-6.
-
(2006)
Am J Hypertens
, vol.19
, pp. 1190-1196
-
-
Burnier, M.1
-
10
-
-
44349111871
-
-
* Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments : Longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-7.
-
* Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments : Longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-7.
-
-
-
-
11
-
-
23944499073
-
Persistence with treatment in newly treated middle-aged patients with essential hypertension
-
Perreault S, Lamarre D, Blais L, et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005;39:1401-8.
-
(2005)
Ann Pharmacother
, vol.39
, pp. 1401-1408
-
-
Perreault, S.1
Lamarre, D.2
Blais, L.3
-
12
-
-
0037166985
-
Long-term persistence in use of statin therapy in elderly patients
-
Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
-
(2002)
JAMA
, vol.288
, pp. 455-461
-
-
Benner, J.S.1
Glynn, R.J.2
Mogun, H.3
-
13
-
-
0041866608
-
Monitoring compliance in resistant hypertension : An important step in patient management
-
Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension : An important step in patient management. J Hypertens 2003;21(Suppl.):S37-42.
-
(2003)
J Hypertens
, vol.21
, Issue.SUPPL.
-
-
Burnier, M.1
Santschi, V.2
Favrat, B.3
Brunner, H.R.4
-
14
-
-
0035144723
-
Electronic compliance monitoring in resistant hypertension : The basis for rational therapeutic decisions
-
Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension : The basis for rational therapeutic decisions. J Hypertens 2001;19:335-41.
-
(2001)
J Hypertens
, vol.19
, pp. 335-341
-
-
Burnier, M.1
Schneider, M.P.2
Chioléro, A.3
Stubi, C.L.4
Brunner, H.R.5
-
15
-
-
0000911287
-
Why objective monitoring of compliance is important in the management of hypertension?
-
Bertholet N, Favrat B, Fallab-Stubl CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension? J Clin Hypertens (Greenwich) 2000;2:258-62.
-
(2000)
J Clin Hypertens (Greenwich)
, vol.2
, pp. 258-262
-
-
Bertholet, N.1
Favrat, B.2
Fallab-Stubl, C.L.3
Brunner, H.R.4
Burnier, M.5
-
16
-
-
33846415962
-
-
* Wetzels GE, Nelemans PJ, Scheuten JS, et al. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 2007;20:119-25.
-
* Wetzels GE, Nelemans PJ, Scheuten JS, et al. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 2007;20:119-25.
-
-
-
-
17
-
-
51449091027
-
Impact of electronic monitoring of drug adherence on blood pressure control in primary care : A 12 month randomised controlled study
-
sous presse
-
Santschi V, Rodondi N, Bugnon O, Burnier M. Impact of electronic monitoring of drug adherence on blood pressure control in primary care : A 12 month randomised controlled study. Eur J Intern Med 2008, sous presse.
-
(2008)
Eur J Intern Med
-
-
Santschi, V.1
Rodondi, N.2
Bugnon, O.3
Burnier, M.4
-
18
-
-
52949115790
-
-
Thèse de doctorat, Faculté des sciences, Université de Genève, Accessible sur, 20 juin
-
Santschi Chioléro V. Adhésion au traitement médicamenteux et suivi électronique : une approche clinique de la prise en charge à long terme du patient chronique dans un réseau ambulatoire patient, pharmacien, médecin. Thèse de doctorat, Faculté des sciences, Université de Genève, 2007. Accessible sur www.unige.ch/cyberdocuments/theses2007/Santschi-ChioleroV/these. pdf (20 juin 2008).
-
(2007)
Adhésion au traitement médicamenteux et suivi électronique : Une approche clinique de la prise en charge à long terme du patient chronique dans un réseau ambulatoire patient, pharmacien, médecin
-
-
Santschi Chioléro, V.1
-
19
-
-
7444240993
-
Les cercles de qualité médecins-pharmaciens : Un réseau local pour maîtriser les coûts et la qualité de la prescription médicale.
-
Bugnon O, Niqullle A, Repond C, Curty C, Nyffeler R. Les cercles de qualité médecins-pharmaciens : un réseau local pour maîtriser les coûts et la qualité de la prescription médicale. Med Hyg 2004;62:2054-8.
-
(2004)
Med Hyg
, vol.62
, pp. 2054-2058
-
-
Bugnon, O.1
Niqullle, A.2
Repond, C.3
Curty, C.4
Nyffeler, R.5
-
20
-
-
0033009996
-
Improved blood pressure control by monitoring compliance with antihypertensive therapy
-
Waeber B, Vetter W, Darioli R, Keller U, Brunner HR. Improved blood pressure control by monitoring compliance with antihypertensive therapy. Int J Clin Pract 1999;53:37-8.
-
(1999)
Int J Clin Pract
, vol.53
, pp. 37-38
-
-
Waeber, B.1
Vetter, W.2
Darioli, R.3
Keller, U.4
Brunner, H.R.5
-
21
-
-
0034937376
-
Treatment strategy to control blood pressure optimally in hypertensive patients
-
Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press 2001;10:62-73.
-
(2001)
Blood Press
, vol.10
, pp. 62-73
-
-
Waeber, B.1
-
22
-
-
0034723758
-
The lipid treatment assessment project (L-TAP) : A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
-
Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP) : A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-67.
-
(2000)
Arch Intern Med
, vol.160
, pp. 459-467
-
-
Pearson, T.A.1
Laurora, I.2
Chu, H.3
Kafonek, S.4
|